What is immunotherapy?

Allergen Specific Immunotherapy (ASIT) is the gold standard for the safe, effective long-term management of atopic dermatitis. Used around the world for over thirty years, its purpose is to normalise the immune response to environmental airborne allergens, such as pollens, dust mites and moulds.

Immunotherapy is the only therapy with the potential to prevent progression of atopic dermatitis.

The goal of successful immunotherapy is to induce immune tolerance and reduce the need for other medication. The therapy is administered via subcutaneous injection every 2 weeks or drops under the tongue twice daily. The flexibility of this approach allows most owners to administer immunotherapy at home.

Is Immunotherapy right for your patient?

  • A diagnosis of atopic dermatitis
  • Successful screening of immunotherapy checklist
  • Processing of patient information

Access to immunotherapy in New Zealand has required referral to a veterinary dermatologist. We are proud to say that RASH is Ministry of Primary Industries (MPI) and Agricultural Compounds and Veterinary Medicines (ACVM) approved to offer immunotherapy by prescription.

You now have the opportunity to offer a long term, proven treatment to patients with atopic dermatitis when referral to a dermatologist is not an option.

Proven effectiveness

Successful response in:

  • 50-70% OF DOGS with atopic dermatitis and
  • 60-80% OF CATS with feline atopic skin syndrome
  • Other success indicators; At least 50% FEWER SKIN AND EAR INFECTIONS

Immunotherapy has a slow onset of action which can be up to 12 months although improvement is to be expected after 6 months for atopic patients. This is why a commitment of 12 months is necessary, and if effective, treatment will most likely be continued for the patient’s lifetime.

Our Process

Successful immunotherapy outcomes depend on the suitability of the patient and client, as well as compliance with the treatment. Our process makes it easy for your clinic to determine if immunotherapy is right for your patient.

  1. A diagnosis of atopic dermatitis
  2. Successful run through of immunotherapy screening checklist.
  3. Processing of patient information.
  4. Blood sample submitted for allergy testing e.g. Heska Allercept IgE serology test.
  5. Analysis of test results and patient history by our registered specialist.
  6. Tailored formulation of immunotherapy treatment and plan.